✦ LIBER ✦
The NF-κB inhibitor DHMEQ decreases survival factors, overcomes the protective activity of microenvironment and synergizes with chemotherapy agents in classical Hodgkin lymphoma
✍ Scribed by Celegato, Marta; Borghese, Cinzia; Umezawa, Kazuo; Casagrande, Naike; Colombatti, Alfonso; Carbone, Antonino; Aldinucci, Donatella
- Book ID
- 122160300
- Publisher
- Elsevier Science
- Year
- 2014
- Tongue
- English
- Weight
- 911 KB
- Volume
- 349
- Category
- Article
- ISSN
- 0304-3835
No coin nor oath required. For personal study only.